Evidence-gap map · non-drug interventions

Non-Hodgkin Lymphoma evidence gaps

83 registered non-drug trials, mapped by approach and outcome.

Which non-drug approaches have been tested for Non-Hodgkin Lymphoma, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

83registered non-drug trials
16with results posted
13recruiting as of 2026-11-16
56group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition. The registry search returned 1,459 trials, more than the 1,000-trial cap, so this map covers the most recently updated 1,000.

none1–23–910–2930 or more
Registered non-drug trials for Non-Hodgkin Lymphoma by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (14)······41 with results1··31 with results11261
Rehabilitation and therapy services (2)······1·······1·
Breathing and respiratory training (1)·······11 with results······11 with results·
Mind-body and psychological approaches (10)2·2311·1·112·131 with results1
Cognitive training and education (10)···1··11·2·1221 with results42
Diet, fasting and nutrition (6)······1····111 with results121
Oxygen, light, temperature and manual therapies (10)1······1····21 with results412
Supplements and nutraceuticals (27)1··1··2··1141 with results83 with results104 with results·62 with results
Care delivery and health services (2)··············11 with results1
Other behavioural, not yet classified (8)··1··111 with results··311 with results··15·

The table scrolls sideways: 16 outcome columns.

No trials found for this condition in: Sleep and circadian approaches; Neuromodulation and electrical stimulation; Other devices and digital tools.

Where the gaps are

This condition has 1,459 matching trials, more than the 1,000 this map covers, so it cannot show that an outcome was never measured. Only studied-but-unreported questions are listed.

Questions studied but with no results posted

  • Exercise and physical activity × feasibility, adherence and safety: 6 trials registered, none with results posted (3 still recruiting)
  • Cognitive training and education × feasibility, adherence and safety: 4 trials registered, none with results posted (1 still recruiting)
  • Oxygen, light, temperature and manual therapies × clinical events, survival and healthcare use: 4 trials registered, none with results posted
  • Mind-body and psychological approaches × mood, anxiety and wellbeing: 3 trials registered, none with results posted (1 still recruiting)

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Non-Hodgkin Lymphoma

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 13 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.